Malignant Hyperthermia Case Studies II
Malignant Hyperthermia (MH) is a rare genetically-linked disease that presents when a patient is exposed to certain anesthesia triggering agents. Recognition of MH is often delayed as the initial symptoms are often confused with other anesthesia events. This program builds upon general knowledge of MH's pathophysiology and recognition by providing case studies that are either MH or not MH-related anesthesia outcomes. Providers of Anesthesia can improve their differential diagnostic skills by taking this course. All scenarios are based upon case studies from the Malignant Hyperthermia Association of the United States.
This education is available on ATMS and Learning Connection. A link to claim credit will be provided to you upon completion.
If you have completed the education on ATMS and Learning Connection click "Take Course" to complete the evaluation and claim credit.
Target Audience
This course is intended for Anesthesia Providers.
Learning Objectives
At the end of this session, learners should be able to:
- Describe signs and symptoms of malignant hyperthermia (MH).
- Distinguish between diagnosis of MH and other disease processes.
- Recognize timeframe of MH symptom presentation.
- Name patient care areas that are most likely to see MH present.
- Identify other patient care areas outside of a hospital where patients might present with MH.
Faculty
Todd Peterson, MD; Advocate Aurora Health
James Ducanto, MD; Advocate Aurora Health
Dennis Brierton, PharmD, System Director Clinical Pharmacy Services; Advocate Aurora Health
Kimberly Mitchell, CNS; Advocate Aurora Health
Disclosure
Faculty Name | Name of Commercial Interest | Nature of Relationship |
James DuCanto, MD | -SSCOR DuCanto Catheter | -Royalties |
The planners and speaker(s) have indicated that there are no other financial relationships with any commercial interests to be disclosed.
Accreditation Statement
Advocate Aurora Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Advocate Aurora Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABA MOCA 2.0® Part 2
This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology™ (MOCA®), known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.
Available Credit
- 1.00 ABA MOCA® II
- 1.00 AMA PRA Category 1 Credit™Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 1.00 AttendanceAttendance Credit
- 1.00 Approved AMA PRA Category 1 Credit™
Price
If you have completed the education on ATMS and Learning Connection click "Take Course" to complete the evaluation and claim credit.
Contact the Advocate Aurora Health CME Office at cme@aah.org if you have any questions or need assistance.